Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Faecal Incontinence in Prostate Cancer Survivors Treated With Moderately Hypofractionated Radiotherapy

NCT04262609 is registered in ClinicalTrials.gov with Consorci Sanitari de Terrassa as lead sponsor.

NCT NCT04262609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04262609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Faecal Incontinence in Prostate Cancer Survivors Treated With Moderately Hypofractionated Radiotherapy
Lead sponsor
Consorci Sanitari de Terrassa
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2019
Completion date
December 1, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

faecal incontinence, prostate cancer